117 related articles for article (PubMed ID: 28593747)
41. NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients.
Boguszewicz Ł; Bieleń A; Mrochem-Kwarciak J; Skorupa A; Ciszek M; Heyda A; Wygoda A; Kotylak A; Składowski K; Sokół M
Metabolomics; 2019 Aug; 15(8):110. PubMed ID: 31420744
[TBL] [Abstract][Full Text] [Related]
42. The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer.
Lou YB; Fan FX; Mu YC; Dong X
J Biol Regul Homeost Agents; 2018; 32(1):75-82. PubMed ID: 29504368
[TBL] [Abstract][Full Text] [Related]
43. Wide spectrum targeted metabolomics identifies potential ovarian cancer biomarkers.
Plewa S; Horała A; Dereziński P; Nowak-Markwitz E; Matysiak J; Kokot ZJ
Life Sci; 2019 Apr; 222():235-244. PubMed ID: 30853626
[TBL] [Abstract][Full Text] [Related]
44. Highly-accurate metabolomic detection of early-stage ovarian cancer.
Gaul DA; Mezencev R; Long TQ; Jones CM; Benigno BB; Gray A; Fernández FM; McDonald JF
Sci Rep; 2015 Nov; 5():16351. PubMed ID: 26573008
[TBL] [Abstract][Full Text] [Related]
45. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
Gupta A; Gupta S; Mahdi AA
Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
[TBL] [Abstract][Full Text] [Related]
46. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
Chen L; Zhang C; Gui Q; Chen Y; Yang Y
Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
[TBL] [Abstract][Full Text] [Related]
47. [Metabonomics study of oral cancer using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry].
He H; Shi X; Chen J; Gao P; Lei Y; Xu G
Se Pu; 2012 Mar; 30(3):245-51. PubMed ID: 22715688
[TBL] [Abstract][Full Text] [Related]
48. Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.
Sanabria JR; Kombu RS; Zhang GF; Sandlers Y; Ai J; Ibarra RA; Abbas R; Goyal K; Brunengraber H
HPB (Oxford); 2016 Dec; 18(12):979-990. PubMed ID: 28340971
[TBL] [Abstract][Full Text] [Related]
49. Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics.
Kang H; Li X; Zhou Q; Quan C; Xue F; Zheng J; Yu Y
Br J Dermatol; 2017 Mar; 176(3):713-722. PubMed ID: 27564527
[TBL] [Abstract][Full Text] [Related]
50. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry.
Chen S; Kong H; Lu X; Li Y; Yin P; Zeng Z; Xu G
Anal Chem; 2013 Sep; 85(17):8326-33. PubMed ID: 23889541
[TBL] [Abstract][Full Text] [Related]
51. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
[TBL] [Abstract][Full Text] [Related]
52. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
53. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
[TBL] [Abstract][Full Text] [Related]
54. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
55. Selection of candidate radiation biomarkers in the serum of rats exposed to gamma-rays by GC/TOFMS-based metabolomics.
Liu H; Wang Z; Zhang X; Qiao Y; Wu S; Dong F; Chen Y
Radiat Prot Dosimetry; 2013 Apr; 154(1):9-17. PubMed ID: 22951997
[TBL] [Abstract][Full Text] [Related]
56. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
[TBL] [Abstract][Full Text] [Related]
57. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
58. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
Pamungkas AD; Park C; Lee S; Jee SH; Park YH
Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
[TBL] [Abstract][Full Text] [Related]
59. Ionizing radiation affects profile of serum metabolites: increased level of 3-hydroxybutyric acid in serum of cancer patients treated with radiotherapy.
Roś-Mazurczyk M; Wojakowska A; Marczak Ł; Polański K; Pietrowska M; Jelonek K; Domińczyk I; Hajduk A; Rutkowski T; Składowski K; Widłak P
Acta Biochim Pol; 2017; 64(1):189-193. PubMed ID: 27815965
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
